These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19321778)

  • 1. Cytokine switch and bystander suppression of autoimmune responses to multiple antigens in experimental autoimmune encephalomyelitis by a single recombinant T-cell receptor ligand.
    Sinha S; Subramanian S; Miller L; Proctor TM; Roberts C; Burrows GG; Vandenbark AA; Offner H
    J Neurosci; 2009 Mar; 29(12):3816-23. PubMed ID: 19321778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A promising therapeutic approach for multiple sclerosis: recombinant T-cell receptor ligands modulate experimental autoimmune encephalomyelitis by reducing interleukin-17 production and inhibiting migration of encephalitogenic cells into the CNS.
    Sinha S; Subramanian S; Proctor TM; Kaler LJ; Grafe M; Dahan R; Huan J; Vandenbark AA; Burrows GG; Offner H
    J Neurosci; 2007 Nov; 27(46):12531-9. PubMed ID: 18003831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch.
    Huan J; Subramanian S; Jones R; Rich C; Link J; Mooney J; Bourdette DN; Vandenbark AA; Burrows GG; Offner H
    J Immunol; 2004 Apr; 172(7):4556-66. PubMed ID: 15034073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of DAB(389)IL-2 immunotoxin on the course of experimental autoimmune encephalomyelitis in Lewis rats.
    Phillips SM; Bhopale MK; Constantinescu CS; Ciric B; Hilliard B; Ventura E; Lavi E; Rostami A
    J Neurol Sci; 2007 Dec; 263(1-2):59-69. PubMed ID: 17603081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mannan-MOG35-55 Reverses Experimental Autoimmune Encephalomyelitis, Inducing a Peripheral Type 2 Myeloid Response, Reducing CNS Inflammation, and Preserving Axons in Spinal Cord Lesions.
    Dagkonaki A; Avloniti M; Evangelidou M; Papazian I; Kanistras I; Tseveleki V; Lampros F; Tselios T; Jensen LT; Möbius W; Ruhwedel T; Androutsou ME; Matsoukas J; Anagnostouli M; Lassmann H; Probert L
    Front Immunol; 2020; 11():575451. PubMed ID: 33329540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitis.
    Sinha S; Miller L; Subramanian S; McCarty OJ; Proctor T; Meza-Romero R; Huan J; Burrows GG; Vandenbark AA; Offner H
    J Neuroimmunol; 2010 Aug; 225(1-2):52-61. PubMed ID: 20546940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-associated changes in rat immune system: lessons learned from experimental autoimmune encephalomyelitis.
    Djikić J; Nacka-Aleksić M; Pilipović I; Stojić-Vukanić Z; Bufan B; Kosec D; Dimitrijević M; Leposavić G
    Exp Gerontol; 2014 Oct; 58():179-97. PubMed ID: 25128713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of encephalitogenic T cells with recombinant TCR ligands.
    Burrows GG; Adlard KL; Bebo BF; Chang JW; Tenditnyy K; Vandenbark AA; Offner H
    J Immunol; 2000 Jun; 164(12):6366-71. PubMed ID: 10843691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of murine experimental autoimmune encephalomyelitis by interleukin-2 receptor targeted fusion toxin, DAB(389)IL-2.
    Phillips SM; Bhopale MK; Hilliard B; Zekavat SA; Ali MA; Rostami A
    Cell Immunol; 2010; 261(2):144-52. PubMed ID: 20042183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice.
    Vandenbark AA; Rich C; Mooney J; Zamora A; Wang C; Huan J; Fugger L; Offner H; Jones R; Burrows GG
    J Immunol; 2003 Jul; 171(1):127-33. PubMed ID: 12816990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral administration of 1,4-aryl-2-mercaptoimidazole inhibits T-cell proliferation and reduces clinical severity in the murine experimental autoimmune encephalomyelitis model.
    Jung EJ; Hur M; Kim YL; Lee GH; Kim J; Kim I; Lee M; Han HK; Kim MS; Hwang S; Kim S; Woo AM; Yoon Y; Park HJ; Won J
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1005-13. PubMed ID: 19741152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-specific therapy promotes repair of myelin and axonal damage in established EAE.
    Wang C; Gold BG; Kaler LJ; Yu X; Afentoulis ME; Burrows GG; Vandenbark AA; Bourdette DN; Offner H
    J Neurochem; 2006 Sep; 98(6):1817-27. PubMed ID: 16899071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LRR domain of NLRX1 protein delivery by dNP2 inhibits T cell functions and alleviates autoimmune encephalomyelitis.
    Koo JH; Kim DH; Cha D; Kang MJ; Choi JM
    Theranostics; 2020; 10(7):3138-3150. PubMed ID: 32194859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of human platelet binding of recombinant T cell receptor ligand.
    Itakura A; Aslan JE; Sinha S; White-Adams TC; Patel IA; Meza-Romero R; Vandenbark AA; Burrows GG; Offner H; McCarty OJ
    J Neuroinflammation; 2010 Nov; 7():75. PubMed ID: 21059245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble mannosylated myelin peptide inhibits the encephalitogenicity of autoreactive T cells during experimental autoimmune encephalomyelitis.
    Kel J; Oldenampsen J; Luca M; Drijfhout JW; Koning F; Nagelkerken L
    Am J Pathol; 2007 Jan; 170(1):272-80. PubMed ID: 17200200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis.
    Diab A; Deng C; Smith JD; Hussain RZ; Phanavanh B; Lovett-Racke AE; Drew PD; Racke MK
    J Immunol; 2002 Mar; 168(5):2508-15. PubMed ID: 11859145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of passive experimental autoimmune encephalomyelitis in SJL mice with a recombinant TCR ligand induces IL-13 and prevents axonal injury.
    Offner H; Subramanian S; Wang C; Afentoulis M; Vandenbark AA; Huan J; Burrows GG
    J Immunol; 2005 Sep; 175(6):4103-11. PubMed ID: 16148160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
    Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
    Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin isolated from parasite inhibits remission of experimental autoimmune encephalomyelitis by up-regulating autoantibody.
    Bing SJ; Ha D; Ahn G; Cho J; Kim A; Park SK; Yu HS; Jee Y
    Clin Exp Immunol; 2015 Jun; 180(3):419-31. PubMed ID: 25619397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of autoimmune anterior uveitis with recombinant TCR ligands.
    Adamus G; Burrows GG; Vandenbark AA; Offner H
    Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2555-61. PubMed ID: 16723470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.